RUNX1 and acute myeloid leukemia: Our previous [7] and current studies expand on these findings by demonstrating that, in addition to mutations, AML cases with copy number gains, and translocations involving RUNX1, other than RUNX1T1 fusion, may also demonstrate B-cell marker expression, imparting a “mixed-lineage-like” immunophenotype in these cases.